v2.4.0.8
Taxes on Income - Reconciliation Between Effective Tax Rate and US Statutory Rate (Detail) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Effective Income Tax Rate Reconciliation, Percent [Abstract]      
U.S. statutory rate applied to income before taxes, Tax rate 35.00% 35.00% 35.00%
Differential arising from:      
Foreign earnings, Tax rate (23.70%) (22.40%) (30.30%)
Tax settlements, Tax rate (9.00%) (1.30%) (9.80%)
The American Taxpayer Relief Act of 2012, Tax rate (4.80%) 0.00% 0.00%
Unremitted foreign earnings, Tax rate (1.50%) (0.10%) (1.20%)
Tax rate changes, Tax rate (0.20%) 0.60% (4.00%)
Amortization of purchase accounting adjustments, Tax rate 16.80% 10.30% 11.90%
Restructuring, Tax rate 4.00% 0.70% 2.20%
U.S. health care reform legislation, Tax rate 1.20% 0.70% 0.70%
Intangible asset impairment charges, Percent 1.00% 0.50% (0.10%)
Vioxx and ENHANCE litigation settlements, Tax rate 0.00% 1.20% 0.00%
Arbitration settlement charge, Tax rate 0.00% 0.00% 2.40%
State taxes, Tax rate 0.80% 0.30% 1.00%
Other, Tax rate (1.10%) [1] 2.40% [1] 5.00% [1]
Total, Tax rate 18.50% 27.90% 12.80%
Effective Income Tax Rate Reconciliation, Amount [Abstract]      
U.S. statutory rate applied to income before taxes, Amount $ 1,941 $ 3,059 $ 2,567
Differential arising from:      
Foreign earnings, Amount (1,316) (1,955) (2,220)
Federal and state tax settlements, Amount (497) (113) (721)
The American Taxpayer Relief Act of 2012, Amount (269) 0 0
Unremitted foreign earnings, Amount (81) (11) (86)
Tax rate changes, Amount (10) 57 (295)
Amortization of purchase accounting adjustments, Amount 934 905 875
Restructuring, Amount 224 62 163
U.S. health care reform legislation, Amount 65 60 50
Intangible asset impairment charges, Amount 56 40 (5)
Vioxx Liability Reserve, Amount 0 98 0
Arbitration settlement charge, Amount 0 0 177
State taxes, Amount 44 31 72
Other, Amount (63) [1] 207 [1] 365 [1]
Taxes on income $ 1,028 $ 2,440 $ 942
[1] Other includes the tax effect of contingency reserves, research credits and miscellaneous items.